chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post vaccination has been reported to our practice.
Age: 53.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Covid breakthrough case
Age: 71.0
Sex: F
Vaccine: COVID19, PPV
Symptoms: Acute kidney injury, Blood creatinine increased, Blood folate normal, Blood iron decreased, COVID-19
Clinical narrative: Discharge Provider: DO Primary Care Provider at Discharge: DO Admission Date: 5/22/2022 Discharge Date: 5/25/2022  HOSPITAL PROBLEMS 1. Covid-19 Infection 2. Diarrhea secondary to Covid-19 3. AKI 4. HTN 5. T2DM 6. IDA 7. COPD 8. GERD 9. HLD 10. RLS  HOSPITAL COURSE: Patient is a 72 y.o. female admitted to hospital due to diarrhea and dehydration secondary to Covid-19 infection.   Covid-19/Diarrhea: Patient admitted with several days of copious diarrhea and subsequent dehydration. She had also been feeling generally unwell, with congestion and rhinorrhea. Was found to be Covid positive on 5/22/2022. Did not have SOB, fever or cough. Was not candidate for steroids or Remdesivir. While thought diarrhea due to Covid infection did not want to overlook bacterial cause so enteric pathogens and C diff were tested which came back negative. Patient was started on IV fluids. Diarrhea began to resolve and patient was tolerating diet. Was able to discharge home.   AKI: On admission Cr 3.32, with baseline 1.0-1.3. Likely prerenal given GI losses and dehydration. Lisinopril and Maxide was held, and she was started on IV fluids, with subsequent improvement in Cr. IV fluids were discontinued when patient had adequate PO intake, and Cr continued to show improvement. Was deemed stable for discharge home with follow up with PCP. Lisinopril and Maxide held at discharge, with repeat BMP ordered for 5/27/2022.    IDA: Patients Hb 8.5 on admission. Vit B12 and folate WNL. Iron low at 26. Was started on Iron supplementation.               EGD 2019:  distal stricture with erosion, moderate HH.               Colon 2017:  5 mm, diminutive polyp - tubular adenoma
Age: 71.0
Sex: F
Vaccine: COVID19, PPV
Symptoms: Chronic obstructive pulmonary disease, Clostridium test negative, Dehydration, Diarrhoea, Gastrointestinal pathogen panel
Clinical narrative: Discharge Provider: DO Primary Care Provider at Discharge: DO Admission Date: 5/22/2022 Discharge Date: 5/25/2022  HOSPITAL PROBLEMS 1. Covid-19 Infection 2. Diarrhea secondary to Covid-19 3. AKI 4. HTN 5. T2DM 6. IDA 7. COPD 8. GERD 9. HLD 10. RLS  HOSPITAL COURSE: Patient is a 72 y.o. female admitted to hospital due to diarrhea and dehydration secondary to Covid-19 infection.   Covid-19/Diarrhea: Patient admitted with several days of copious diarrhea and subsequent dehydration. She had also been feeling generally unwell, with congestion and rhinorrhea. Was found to be Covid positive on 5/22/2022. Did not have SOB, fever or cough. Was not candidate for steroids or Remdesivir. While thought diarrhea due to Covid infection did not want to overlook bacterial cause so enteric pathogens and C diff were tested which came back negative. Patient was started on IV fluids. Diarrhea began to resolve and patient was tolerating diet. Was able to discharge home.   AKI: On admission Cr 3.32, with baseline 1.0-1.3. Likely prerenal given GI losses and dehydration. Lisinopril and Maxide was held, and she was started on IV fluids, with subsequent improvement in Cr. IV fluids were discontinued when patient had adequate PO intake, and Cr continued to show improvement. Was deemed stable for discharge home with follow up with PCP. Lisinopril and Maxide held at discharge, with repeat BMP ordered for 5/27/2022.    IDA: Patients Hb 8.5 on admission. Vit B12 and folate WNL. Iron low at 26. Was started on Iron supplementation.               EGD 2019:  distal stricture with erosion, moderate HH.               Colon 2017:  5 mm, diminutive polyp - tubular adenoma
Age: 71.0
Sex: F
Vaccine: COVID19, PPV
Symptoms: Gastrooesophageal reflux disease, Haemoglobin decreased, Hyperlipidaemia, Hypertension, Iron deficiency anaemia
Clinical narrative: Discharge Provider: DO Primary Care Provider at Discharge: DO Admission Date: 5/22/2022 Discharge Date: 5/25/2022  HOSPITAL PROBLEMS 1. Covid-19 Infection 2. Diarrhea secondary to Covid-19 3. AKI 4. HTN 5. T2DM 6. IDA 7. COPD 8. GERD 9. HLD 10. RLS  HOSPITAL COURSE: Patient is a 72 y.o. female admitted to hospital due to diarrhea and dehydration secondary to Covid-19 infection.   Covid-19/Diarrhea: Patient admitted with several days of copious diarrhea and subsequent dehydration. She had also been feeling generally unwell, with congestion and rhinorrhea. Was found to be Covid positive on 5/22/2022. Did not have SOB, fever or cough. Was not candidate for steroids or Remdesivir. While thought diarrhea due to Covid infection did not want to overlook bacterial cause so enteric pathogens and C diff were tested which came back negative. Patient was started on IV fluids. Diarrhea began to resolve and patient was tolerating diet. Was able to discharge home.   AKI: On admission Cr 3.32, with baseline 1.0-1.3. Likely prerenal given GI losses and dehydration. Lisinopril and Maxide was held, and she was started on IV fluids, with subsequent improvement in Cr. IV fluids were discontinued when patient had adequate PO intake, and Cr continued to show improvement. Was deemed stable for discharge home with follow up with PCP. Lisinopril and Maxide held at discharge, with repeat BMP ordered for 5/27/2022.    IDA: Patients Hb 8.5 on admission. Vit B12 and folate WNL. Iron low at 26. Was started on Iron supplementation.               EGD 2019:  distal stricture with erosion, moderate HH.               Colon 2017:  5 mm, diminutive polyp - tubular adenoma
Age: 71.0
Sex: F
Vaccine: COVID19, PPV
Symptoms: Malaise, Respiratory tract congestion, Restless legs syndrome, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Discharge Provider: DO Primary Care Provider at Discharge: DO Admission Date: 5/22/2022 Discharge Date: 5/25/2022  HOSPITAL PROBLEMS 1. Covid-19 Infection 2. Diarrhea secondary to Covid-19 3. AKI 4. HTN 5. T2DM 6. IDA 7. COPD 8. GERD 9. HLD 10. RLS  HOSPITAL COURSE: Patient is a 72 y.o. female admitted to hospital due to diarrhea and dehydration secondary to Covid-19 infection.   Covid-19/Diarrhea: Patient admitted with several days of copious diarrhea and subsequent dehydration. She had also been feeling generally unwell, with congestion and rhinorrhea. Was found to be Covid positive on 5/22/2022. Did not have SOB, fever or cough. Was not candidate for steroids or Remdesivir. While thought diarrhea due to Covid infection did not want to overlook bacterial cause so enteric pathogens and C diff were tested which came back negative. Patient was started on IV fluids. Diarrhea began to resolve and patient was tolerating diet. Was able to discharge home.   AKI: On admission Cr 3.32, with baseline 1.0-1.3. Likely prerenal given GI losses and dehydration. Lisinopril and Maxide was held, and she was started on IV fluids, with subsequent improvement in Cr. IV fluids were discontinued when patient had adequate PO intake, and Cr continued to show improvement. Was deemed stable for discharge home with follow up with PCP. Lisinopril and Maxide held at discharge, with repeat BMP ordered for 5/27/2022.    IDA: Patients Hb 8.5 on admission. Vit B12 and folate WNL. Iron low at 26. Was started on Iron supplementation.               EGD 2019:  distal stricture with erosion, moderate HH.               Colon 2017:  5 mm, diminutive polyp - tubular adenoma
Age: 71.0
Sex: F
Vaccine: COVID19, PPV
Symptoms: Type 2 diabetes mellitus, Vitamin B12 normal
Clinical narrative: Discharge Provider: DO Primary Care Provider at Discharge: DO Admission Date: 5/22/2022 Discharge Date: 5/25/2022  HOSPITAL PROBLEMS 1. Covid-19 Infection 2. Diarrhea secondary to Covid-19 3. AKI 4. HTN 5. T2DM 6. IDA 7. COPD 8. GERD 9. HLD 10. RLS  HOSPITAL COURSE: Patient is a 72 y.o. female admitted to hospital due to diarrhea and dehydration secondary to Covid-19 infection.   Covid-19/Diarrhea: Patient admitted with several days of copious diarrhea and subsequent dehydration. She had also been feeling generally unwell, with congestion and rhinorrhea. Was found to be Covid positive on 5/22/2022. Did not have SOB, fever or cough. Was not candidate for steroids or Remdesivir. While thought diarrhea due to Covid infection did not want to overlook bacterial cause so enteric pathogens and C diff were tested which came back negative. Patient was started on IV fluids. Diarrhea began to resolve and patient was tolerating diet. Was able to discharge home.   AKI: On admission Cr 3.32, with baseline 1.0-1.3. Likely prerenal given GI losses and dehydration. Lisinopril and Maxide was held, and she was started on IV fluids, with subsequent improvement in Cr. IV fluids were discontinued when patient had adequate PO intake, and Cr continued to show improvement. Was deemed stable for discharge home with follow up with PCP. Lisinopril and Maxide held at discharge, with repeat BMP ordered for 5/27/2022.    IDA: Patients Hb 8.5 on admission. Vit B12 and folate WNL. Iron low at 26. Was started on Iron supplementation.               EGD 2019:  distal stricture with erosion, moderate HH.               Colon 2017:  5 mm, diminutive polyp - tubular adenoma
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: No adverse reaction.  Vaccine temperature excursion.  Vaccine was kept at a frozen temperature, not refrigerated temperature upon receipt of shipment.
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Chest pain, Cough, Haemoptysis, Pain
Clinical narrative: Pt states that she tested positive for COVID at home.  She had been treated with a course of Paxlovid and presents with sudden onset of chest pain and blood-tinged sputum.  Pt has a cough, no fever, but body aches.  She did test positive for COVID on PCR at the hospital.
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Pt states that she tested positive for COVID at home.  She had been treated with a course of Paxlovid and presents with sudden onset of chest pain and blood-tinged sputum.  Pt has a cough, no fever, but body aches.  She did test positive for COVID on PCR at the hospital.
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post vaccination has been reported to our practice.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Swelling, Urticaria
Clinical narrative: Hives on feet, cervical spine, bra-line, both arms, near the right eye, shoulders, panty-line, rectal area, left thumb and index finger.  They itch and are swollen.
Age: 17.0
Sex: M
Vaccine: MNQ
Symptoms: Dizziness, Hyperhidrosis, Nausea
Clinical narrative: Patient developed nausea, dizziness, and diaphoresis within two minutes of injection. Patient was assisted to side-lying position and ice pack placed on head/neck, wet washcloth to face. No vomiting, no syncope. Patient returned to baseline within 10 minutes. Declined offer of juice and pretzels. Recommended to RTC should they experience any other symptoms.
Age: 91.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Arthritis bacterial, COVID-19, Cellulitis, Death
Clinical narrative: 2/16/22 pt presents to hosp with lethargy and poor appetite; hx of positive COVID test on 1/22/22; admitted with encephalopathy metabolic secondary cellulitis vs in-patient delerium; probable cellulitis RUE vs septic joint; IV ABX; AKI; pt made DNR/DNI, no feeding tubes or artificial nutrition; transitioned to comfort care/hospice; pt passed away in the hospital
Age: 91.0
Sex: M
Vaccine: COVID19
Symptoms: Decreased appetite, Delirium, Lethargy, Metabolic encephalopathy, SARS-CoV-2 test positive
Clinical narrative: 2/16/22 pt presents to hosp with lethargy and poor appetite; hx of positive COVID test on 1/22/22; admitted with encephalopathy metabolic secondary cellulitis vs in-patient delerium; probable cellulitis RUE vs septic joint; IV ABX; AKI; pt made DNR/DNI, no feeding tubes or artificial nutrition; transitioned to comfort care/hospice; pt passed away in the hospital
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: No adverse reaction.  Vaccine temperature excursion.  Vaccine was kept at a frozen temperature, not refrigerated temperature upon receipt of shipment.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post vaccination has been reported to our practice.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Fatigue, Feeling abnormal, Pain, Pyrexia
Clinical narrative: I didn't feel poorly until I went to the dentist on 5/25. They did a panoramic x-ray and said that one of my sinuses were completely full. I came home and called my doctor because I had had a sinus infection in March. I did a tele visit with her and she advised that I give it a few days and see what happens. That night, I was feeling really bad. At the advise of my daughter, I took an at home COVID test and that was positive. I was still feeling badly that next morning, so I took another COVID test which was also positive. I was feeling body aches, fatigue, fever like (I did not have a thermometer.) I spoke with my doctor again to inform them of my positive results. She prescribed a round of PAXLOVID. I finished that yesterday morning, 5/31. The medication didn't really help my symptoms, but the very last morning, 5/31, I woke up feeling better.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Sinus congestion, Sinusitis, X-ray dental
Clinical narrative: I didn't feel poorly until I went to the dentist on 5/25. They did a panoramic x-ray and said that one of my sinuses were completely full. I came home and called my doctor because I had had a sinus infection in March. I did a tele visit with her and she advised that I give it a few days and see what happens. That night, I was feeling really bad. At the advise of my daughter, I took an at home COVID test and that was positive. I was still feeling badly that next morning, so I took another COVID test which was also positive. I was feeling body aches, fatigue, fever like (I did not have a thermometer.) I spoke with my doctor again to inform them of my positive results. She prescribed a round of PAXLOVID. I finished that yesterday morning, 5/31. The medication didn't really help my symptoms, but the very last morning, 5/31, I woke up feeling better.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Irritability, Mobility decreased, Myalgia
Clinical narrative: I developed a sore arm. The next day I was very sore, extreme fatigue, muscle aches and feeling "out of it". Emotionally I felt very jumpy and irritable which is very much not like me. For two weeks I stayed in bed. I did not take anything to help elevate my symptoms.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Nervousness, Pain, Pain in extremity
Clinical narrative: I developed a sore arm. The next day I was very sore, extreme fatigue, muscle aches and feeling "out of it". Emotionally I felt very jumpy and irritable which is very much not like me. For two weeks I stayed in bed. I did not take anything to help elevate my symptoms.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Abdominal pain lower, COVID-19, Chest pain, Cholelithiasis, Nausea
Clinical narrative: Patient admitted 5/17. The patient complains of left and right lower abdominal pain associated with nausea and vomiting.  She was evaluated in the ED and was found to have COVID-19 infection 5/17.  Patient also complained of having chest pain.  Patient describes that her chest pain started before the nausea and vomiting and feels like a sting and then the nausea and vomiting started.  She describes having a syncopal event PTA. Patient does have a history of chronic abdominal pain.  The patient underwent an ultrasound of the abdomen, which revealed findings consistent with cholelithiasis, no evidence of cholecystitis.  No fevers, no chills. Dishcharged home 5/22.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pain, Syncope, Ultrasound abdomen abnormal, Vomiting
Clinical narrative: Patient admitted 5/17. The patient complains of left and right lower abdominal pain associated with nausea and vomiting.  She was evaluated in the ED and was found to have COVID-19 infection 5/17.  Patient also complained of having chest pain.  Patient describes that her chest pain started before the nausea and vomiting and feels like a sting and then the nausea and vomiting started.  She describes having a syncopal event PTA. Patient does have a history of chronic abdominal pain.  The patient underwent an ultrasound of the abdomen, which revealed findings consistent with cholelithiasis, no evidence of cholecystitis.  No fevers, no chills. Dishcharged home 5/22.
Age: 65.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Atrial fibrillation, Brain natriuretic peptide increased, COVID-19, COVID-19 pneumonia, Cardioversion
Clinical narrative: Admission Date: 5/22/2022 Discharge Date: May 27, 2022  PRESENTING PROBLEM: Atrial fibrillation with rapid ventricular response Pneumonia due to COVID-19 virus   HOSPITAL COURSE: Patient is a 66 year old man with a history of HTN, HLD, Afib with RVR who presented to the ER due to worsening dyspnea and fatigue .Found to be in Afib with RVR requiring 4 l of oxygen . CXR was consistent with pulmonary edema with BNP 3600. He was started on IV lasix and cardiology was consulted. He underwent Cardioversion which helped with his AFib with RVR , ECHO showed preserved ejection fraction. He was started on short acting cardizem 60 q6 hours along with toprol XL . But due to significant drop in HRs to 40s , metoprolol was held and cardizem dose was changed to long acting cardizem 120 mg daily. Patient was able to go on room air with diuresis and his symptoms significantly improved. Plan is he will follow with cardiology as outpatient for titration of cardizem dose . He also was treated with decadron at the hospital as he was found to have positive COVID this hospitalization. Remdisivir was not given as he was outside the window.
Age: 65.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Chest X-ray abnormal, Condition aggravated, Dyspnoea, Echocardiogram abnormal, Ejection fraction abnormal
Clinical narrative: Admission Date: 5/22/2022 Discharge Date: May 27, 2022  PRESENTING PROBLEM: Atrial fibrillation with rapid ventricular response Pneumonia due to COVID-19 virus   HOSPITAL COURSE: Patient is a 66 year old man with a history of HTN, HLD, Afib with RVR who presented to the ER due to worsening dyspnea and fatigue .Found to be in Afib with RVR requiring 4 l of oxygen . CXR was consistent with pulmonary edema with BNP 3600. He was started on IV lasix and cardiology was consulted. He underwent Cardioversion which helped with his AFib with RVR , ECHO showed preserved ejection fraction. He was started on short acting cardizem 60 q6 hours along with toprol XL . But due to significant drop in HRs to 40s , metoprolol was held and cardizem dose was changed to long acting cardizem 120 mg daily. Patient was able to go on room air with diuresis and his symptoms significantly improved. Plan is he will follow with cardiology as outpatient for titration of cardizem dose . He also was treated with decadron at the hospital as he was found to have positive COVID this hospitalization. Remdisivir was not given as he was outside the window.
Age: 65.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Fatigue, Heart rate decreased, Polyuria, Pulmonary oedema, SARS-CoV-2 test positive
Clinical narrative: Admission Date: 5/22/2022 Discharge Date: May 27, 2022  PRESENTING PROBLEM: Atrial fibrillation with rapid ventricular response Pneumonia due to COVID-19 virus   HOSPITAL COURSE: Patient is a 66 year old man with a history of HTN, HLD, Afib with RVR who presented to the ER due to worsening dyspnea and fatigue .Found to be in Afib with RVR requiring 4 l of oxygen . CXR was consistent with pulmonary edema with BNP 3600. He was started on IV lasix and cardiology was consulted. He underwent Cardioversion which helped with his AFib with RVR , ECHO showed preserved ejection fraction. He was started on short acting cardizem 60 q6 hours along with toprol XL . But due to significant drop in HRs to 40s , metoprolol was held and cardizem dose was changed to long acting cardizem 120 mg daily. Patient was able to go on room air with diuresis and his symptoms significantly improved. Plan is he will follow with cardiology as outpatient for titration of cardizem dose . He also was treated with decadron at the hospital as he was found to have positive COVID this hospitalization. Remdisivir was not given as he was outside the window.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Patient received 4th booster at age 49; uncertain of immunocompromised status
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post vaccination has been reported to our practice.
Age: 20.0
Sex: F
Vaccine: PPV
Symptoms: Wrong product administered
Clinical narrative: PPSV23 administered instead of new guidelines recommending PCV20.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: No adverse reaction.  Vaccine temperature excursion.  Vaccine was kept at a frozen temperature, not refrigerated temperature upon receipt of shipment.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: CLIENT RECEIVED J&J VACCINE AT 17YO. J&J IS APPROVED FOR AGES 18 AND ABOVE.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Fatigue, Headache, Malaise
Clinical narrative: COVID breakthrough case. I received my 2nd booster shot on 04/19/2022 and my COVID symptoms started on  05/28/2022 around 1-2PM I had a scratchy throat and by the evening I had a low grade fever, headache, tired, fatigue, I  didn't feel like doing anything, exhausted, I felt like I wanted to go sleep. 05/29/2022 I developed cough. I did a COVID home test on 05/29/2022 which was positive. I did a telehealth on 05/30/2022 with a nurse from the health clinic. She  contacted my doctor to get an ok from her about giving medications. She then prescribed me PAXLOVID for 5 days but since it was a holiday it did not arrived till this morning 06/01/2022 but since I am felling better I decided not to take it. I am recovering without medication.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive, Somnolence, Throat irritation, Vaccine breakthrough infection
Clinical narrative: COVID breakthrough case. I received my 2nd booster shot on 04/19/2022 and my COVID symptoms started on  05/28/2022 around 1-2PM I had a scratchy throat and by the evening I had a low grade fever, headache, tired, fatigue, I  didn't feel like doing anything, exhausted, I felt like I wanted to go sleep. 05/29/2022 I developed cough. I did a COVID home test on 05/29/2022 which was positive. I did a telehealth on 05/30/2022 with a nurse from the health clinic. She  contacted my doctor to get an ok from her about giving medications. She then prescribed me PAXLOVID for 5 days but since it was a holiday it did not arrived till this morning 06/01/2022 but since I am felling better I decided not to take it. I am recovering without medication.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Dysgeusia, Fatigue, General physical health deterioration, Pain in extremity, Vitreous detachment
Clinical narrative: The same day as very sore arm, metallic taste in mouth. The next day very fatigued. Did not see a doctor. Change in health Posterior Detachment.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Patient received 4th booster ~1 week early. 3rd booster was received 1/11/22
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post vaccination has been reported to our practice.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post vaccination has been reported to our practice.
Age: 38.0
Sex: F
Vaccine: UNK
Symptoms: Back pain, Body temperature fluctuation, Chills, Exposure during pregnancy, Feeling cold
Clinical narrative: She got her vaccine and started having immediate pain in her back.  It got worse in the evening, and her temperature has been going up and down.  Her temperature has not been measured.  She is currently 6 weeks pregnant.  She does not know if she is having reactions to the pregnancy or from the vaccine.  This morning she was freezing cold with shivering.  She put a lot of blankets on her and got in the tub and put hot water in it.  Her teeth were chattering, and her head was hurting as well and could not get warm.  She drank some tea and then got too hot.  She did not want to take any medication due to being pregnant.  She is still having intermittent fever and having the chills/sweats.
Age: 38.0
Sex: F
Vaccine: UNK
Symptoms: Feeling hot, Headache, Hyperhidrosis, Immediate post-injection reaction, Pyrexia
Clinical narrative: She got her vaccine and started having immediate pain in her back.  It got worse in the evening, and her temperature has been going up and down.  Her temperature has not been measured.  She is currently 6 weeks pregnant.  She does not know if she is having reactions to the pregnancy or from the vaccine.  This morning she was freezing cold with shivering.  She put a lot of blankets on her and got in the tub and put hot water in it.  Her teeth were chattering, and her head was hurting as well and could not get warm.  She drank some tea and then got too hot.  She did not want to take any medication due to being pregnant.  She is still having intermittent fever and having the chills/sweats.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling cold, Hyperhidrosis, Hypertension, Pain, Paraesthesia
Clinical narrative: Within 5 minutes of getting the shot down my left arm, I had a lot of tingling which continued 4-5 days. I also had within couple of hours, had chills, low grade fever and some body aches. Then I had the sweats and my blood pressure went 170/110. I called the doctor due to my blood pressure. All my symptoms were not pleasant and this lasted about 5 days.   My blood pressure then came down to 150/64 about one week later and my doctor he said that if my blood pressure went high again for me to go to the ER. It took a good week to get back to normal. I have recovered from my symptoms.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Within 5 minutes of getting the shot down my left arm, I had a lot of tingling which continued 4-5 days. I also had within couple of hours, had chills, low grade fever and some body aches. Then I had the sweats and my blood pressure went 170/110. I called the doctor due to my blood pressure. All my symptoms were not pleasant and this lasted about 5 days.   My blood pressure then came down to 150/64 about one week later and my doctor he said that if my blood pressure went high again for me to go to the ER. It took a good week to get back to normal. I have recovered from my symptoms.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Breakthrough COVID infection
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Chest injury, Dyspnoea, Epistaxis, Haemoptysis
Clinical narrative: Patient admitted 5/18 with complaint of SOB, epistaxis, and had a syncopal episode while at PCP office. Injury to lower left anterior ribs and INR was elevated.  COVID test came back positive 5/18. Patient continues to have occasional nose bleeds and continues to cough up scant amount of blood. Patient was seen and started on remdesivir and also on ceftriaxone. Patient did  complain of cough and shortness of breath denied any chest pain no nausea no vomiting no frequency urgency no dysuria hematochezia hematemesis melena no dizziness no diaphoresis no bleeding and no rash 5/23. Discharged home 5/25.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: International normalised ratio increased, SARS-CoV-2 test positive, Syncope
Clinical narrative: Patient admitted 5/18 with complaint of SOB, epistaxis, and had a syncopal episode while at PCP office. Injury to lower left anterior ribs and INR was elevated.  COVID test came back positive 5/18. Patient continues to have occasional nose bleeds and continues to cough up scant amount of blood. Patient was seen and started on remdesivir and also on ceftriaxone. Patient did  complain of cough and shortness of breath denied any chest pain no nausea no vomiting no frequency urgency no dysuria hematochezia hematemesis melena no dizziness no diaphoresis no bleeding and no rash 5/23. Discharged home 5/25.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Fatigue, Malaise, Respiratory tract congestion
Clinical narrative: I thought I was having allergies. I had lots of congestion and was more tired than normal. I had some nasal drainage and a throat tickle and a small cough. My son had tested positive on the day that I got my second booster which was the 24th. I have not been around him much and he has been able to stay away from the family. Through the weekend I got a stuffed-up head and I was even more tired and ended up napping because of being tired. The scratchy throat continued and has been bothering me still. Monday night I took a home test and it was positive and then I went to urgent care the next day and they did a COVID-19 PCR test which was positive. They gave me PAXLOVID if I wanted to use it but I have not taken it as this point because my symptoms have really been more like bad allergies. At this point my symptoms have not worsened and really stayed the same this far.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea, SARS-CoV-2 test positive, Sinus congestion, Somnolence, Throat irritation
Clinical narrative: I thought I was having allergies. I had lots of congestion and was more tired than normal. I had some nasal drainage and a throat tickle and a small cough. My son had tested positive on the day that I got my second booster which was the 24th. I have not been around him much and he has been able to stay away from the family. Through the weekend I got a stuffed-up head and I was even more tired and ended up napping because of being tired. The scratchy throat continued and has been bothering me still. Monday night I took a home test and it was positive and then I went to urgent care the next day and they did a COVID-19 PCR test which was positive. They gave me PAXLOVID if I wanted to use it but I have not taken it as this point because my symptoms have really been more like bad allergies. At this point my symptoms have not worsened and really stayed the same this far.
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post.
Age: 9.0
Sex: M
Vaccine: COVID19
Symptoms: Axillary pain, Chills, Fatigue, Induration, Injection site rash
Clinical narrative: PT had a fever/ chills and fatigue off and on 5/28 and 5/29. He had a small mild rash at the injection site (left shoulder). He got huge swollen lymph nodes on his neck and axilla. His axilla was swollen (and painful) to the size of a racket ball about 6cm wide and 3 cm thick. His axilla is still tender today  but the swelling is much improved. His neck had a firm swollen node 2cm×1 cm on Saturday-Sunday. We treated him with occasional Tylenol and ibuprofen.
Age: 9.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy, Pyrexia, Swelling, Tenderness
Clinical narrative: PT had a fever/ chills and fatigue off and on 5/28 and 5/29. He had a small mild rash at the injection site (left shoulder). He got huge swollen lymph nodes on his neck and axilla. His axilla was swollen (and painful) to the size of a racket ball about 6cm wide and 3 cm thick. His axilla is still tender today  but the swelling is much improved. His neck had a firm swollen node 2cm×1 cm on Saturday-Sunday. We treated him with occasional Tylenol and ibuprofen.
Age: 56.0
Sex: F
Vaccine: PPV
Symptoms: Wrong product administered
Clinical narrative: PPSV23 administered instead of new guidelines for PCV20.
Age: 93.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post vaccination has been reported to our practice.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Cardiac murmur, Chest pain, Fatigue
Clinical narrative: Around 5/4/22 had a 2 day period of extreme fatigue. No fever but developed an ache in my left chest area. Felt like I was experiencing heart murmurs.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post vaccination has been reported to our practice.
Age: 48.0
Sex: F
Vaccine: UNK
Symptoms: Anaphylactic reaction, Blood test, Dyspnoea, Tachycardia, Wheezing
Clinical narrative: Anaphylaxis - marked difficulty breathing ,wheezing, and tachycardia
Age: 48.0
Sex: F
Vaccine: UNK
Symptoms: X-ray
Clinical narrative: Anaphylaxis - marked difficulty breathing ,wheezing, and tachycardia
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Dizziness, Mobility decreased, Rash, Rash pruritic
Clinical narrative: I received my vaccine 11/30/2021. On 12/17/2021 I noticed I had a rash and itchy spot where I had a bandage on. About 3 months after I noticed more bumps and swelling with blisters under my birth control patch. I notified my doctor and was told that I was becoming very sensitive to adhesives on skin contact with symptoms showing after five to ten mins. Also after receiving the vaccine the next day I woke up and was unable to get out of bed. I was experiencing extreme dizziness. I was unable to function for about 2 days.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Sensitive skin, Swelling
Clinical narrative: I received my vaccine 11/30/2021. On 12/17/2021 I noticed I had a rash and itchy spot where I had a bandage on. About 3 months after I noticed more bumps and swelling with blisters under my birth control patch. I notified my doctor and was told that I was becoming very sensitive to adhesives on skin contact with symptoms showing after five to ten mins. Also after receiving the vaccine the next day I woke up and was unable to get out of bed. I was experiencing extreme dizziness. I was unable to function for about 2 days.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post vaccination has been reported to our practice.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post vaccination has been reported to our practice.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Fatigue, Feeling abnormal, Nasal congestion
Clinical narrative: Breakthrough COVID case: My husband and I received our boosters on the same day, May 11th. He tested negative twice after that. I started feeling a scratchy throat one week after my shot. I tested that day and it was negative. I assumed it was a cold like my husband had. Two days later, on Friday, we were expecting a guest. I tested again and it was positive. My husband tested again and, this time, he was positive, too. I called the doctor's office and spoke with the nurse. Because of the high cholesterol, she prescribed PAXLOVID for me. I had an appointment already scheduled to see my doctor on May 25th so we spoke about COVID then, but, by then, I was pretty much getting better. That was Dr. that I saw that day.  I was feeling, not feverish, but pretty run down for the first couple of days. The Paxlovid seemed to help a lot pretty quickly. My symptoms didn't get as severe as my husband's and it's usually the other way around. My symptoms were mostly stuffy and congested with a cough, sore throat, and fatigue. Once I started taking Paxlovid, it all started alleviating pretty quickly.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Respiratory tract congestion, SARS-CoV-2 test positive, Throat irritation, Vaccine breakthrough infection
Clinical narrative: Breakthrough COVID case: My husband and I received our boosters on the same day, May 11th. He tested negative twice after that. I started feeling a scratchy throat one week after my shot. I tested that day and it was negative. I assumed it was a cold like my husband had. Two days later, on Friday, we were expecting a guest. I tested again and it was positive. My husband tested again and, this time, he was positive, too. I called the doctor's office and spoke with the nurse. Because of the high cholesterol, she prescribed PAXLOVID for me. I had an appointment already scheduled to see my doctor on May 25th so we spoke about COVID then, but, by then, I was pretty much getting better. That was Dr. that I saw that day.  I was feeling, not feverish, but pretty run down for the first couple of days. The Paxlovid seemed to help a lot pretty quickly. My symptoms didn't get as severe as my husband's and it's usually the other way around. My symptoms were mostly stuffy and congested with a cough, sore throat, and fatigue. Once I started taking Paxlovid, it all started alleviating pretty quickly.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Joint stiffness, Lymphadenopathy, Muscle tightness, Skin warm, Swelling
Clinical narrative: Swollen lymph node above the left collarbone, and it felt warm. Tightness in my shoulder up to the neck. I had swelling on my left side and tenderness. Was not given any medication for it, was just told to leave it alone. I took TYLENOL and did ice it. The swelling went down in about 5 days. Still a bit tender, but not hurting much anymore.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Tenderness
Clinical narrative: Swollen lymph node above the left collarbone, and it felt warm. Tightness in my shoulder up to the neck. I had swelling on my left side and tenderness. Was not given any medication for it, was just told to leave it alone. I took TYLENOL and did ice it. The swelling went down in about 5 days. Still a bit tender, but not hurting much anymore.
Age: 2.0
Sex: F
Vaccine: MMRV
Symptoms: No adverse event, Wrong product administered
Clinical narrative: No adverse reaction. Child was given MMR and MMRV and should have gotten MMR and Varicella. Parent was contacted and child was reported to be doing fine.  This was a vaccine administration error on my part.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: No adverse reaction.  Vaccine temperature excursion.  Vaccine was kept at a frozen temperature, not refrigerated temperature upon receipt of shipment.
Age: 95.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post vaccination has been reported to our practice.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Blindness unilateral, Swelling face, Vision blurred
Clinical narrative: States vision got blurry this morning and sees nothing out of left eye. Also swelling right side of face.